Complex PCI: Complex Characteristics Impact Results

Patients with a bigger number of complex anatomical characteristics that increase PCI complexity have worse results at one-year followup.

Angioplastias complejas

These data come from a large multicenter study (e-Ultimaster) recently published in EuroIntervention.

The more complex the characteristics, the greater the increase in events. 

It is important to see past the obvious anatomical challenges (bifurcations, calcification, multivessel disease, etc.) and keep a wider perspective. A patient is much more than their coronary arteries. Complexity procedure also contributes (atherectomy, hemodynamic support).

PCI complexity is not a binary variable. There is an infinite range of greys in between with a dose/response outcome curve. Each point contributes to complexity and to increased hazard ratio. 


Read also: Drug-Coated Balloons in Critical Ischemia: The Paradigm of Randomized Evidence vs. Logbooks.


In this study in particular, the authors define complexity based on factors used by the 2017  European guidelines for dual antiplatelet therapy. These factors give us a general idea, but we still need a standardized definition. 

The analysis included 35839 patients (mean age 64) undergoing coronary PCI between 2014 and 2018 with Ultimaster DES.

Risk characteristics were: multivessel disease, at least three stents, at least three lesions, bifurcations with at least 2 stents, total length covered with stents of 60 mm or more and chronic total occlusion. 27.3% of patients presented at least one risk characteristic but the vast majority presented more than one (73.3%), most frequently multivessel PCI, with 16.3%.


Read also: Death, Stroke, and Hospitalization while Waiting for TAVR.


Patients with more risk characteristics tended to be older, have more comorbidities, and chronic coronary syndrome. 

At one-year followup, target vessel failure rate was significantly higher in patients with at least one risk characteristic vs. patients with no risk characteristics for both the combined end point and its separate components. End points such as cardiac death (HR 1.28; CI 95% 1.05-1.55), target vessel related MI (HR 1.48; CI 95% 1.18-1.86) and clinically driven revascularization (HR 1.42; CI 95% 1.20-1.68) were associated to PCI complexity. 

Increased risk characteristics involve increased adverse events rate which, in addition to the ones mentioned, includes stent thrombosis. 


Read also: Long-Term Cardiovascular Effects of COVID-19.


Bifurcations increased target vessel failure rate by close to 100% (HR 2.01; 95% CI 1.55-2.62).

Bleeding risk resulted similar in both groups at 30 days, but after a year, patients with complex PCI characteristics had more bleeding events. 

This might be explained because some risk factors are common to both ischemic and bleeding events, such as hypertension, diabetes, kidney failure and old age. 

impact-of-coronary-lesion-complexity-in-percutaneous-coronary-intervention-one-y

Original Title: Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry.

Reference: Mohamed MO et al. EuroIntervention. 2020;16:603-612.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...